Suppr超能文献

采用人脐静脉内皮细胞提取物和高效液相色谱-质谱联用技术,对少腹逐瘀汤中的潜在生物活性成分进行筛选和分析。

Screening and analyzing the potential bioactive components from Shaofu Zhuyu decoction, using human umbilical vein endothelial cell extraction and high-performance liquid chromatography coupled with mass spectrometry.

作者信息

Su Shu-Lan, Yu Li, Hua Yong-Qing, Duan Jin-Ao, Deng Hai-Shan, Tang Yu-Ping, Lu Yin, Ding An-Wei

机构信息

Jiangsu Key laboratory for TCM Formulae Research, Nanjing University of Chinese Medicine, Nanjing 210046, People's Republic of China.

出版信息

Biomed Chromatogr. 2008 Dec;22(12):1385-92. doi: 10.1002/bmc.1070.

Abstract

In this paper, a useful method for screening and analyzing the potential bioactive components in bioassay-guided fraction (SF-11) from Shaofu Zhuyu decoction was developed using human umbilical vein endothelial cell (HUVEC) extraction and high-performance liquid chromatography coupled with Q-TOF/MS spectrometry. In addition, the protective effects on HUVEC damage induced by adrenaline in vitro were also investigated. The results showed that SF-11 significantly inhibited the endothelin (ET) release and reversed the NO secretion of HUVEC (p < 0.05), and promoted the PGI(2) release of HUVEC (p < 0.05). Two effective components, paeoniflorin and typhaneoside, from SF-11 were screened and identified using live cell extract and HPLC coupled with Q-TOF/MS spectrometry. The compounds, paeoniflorin and typhaneoside, showed significantly inhibiting effects on the ET release and reversing of NO secretion of HUVEC (p < 0.05), with similar effects to SF-11, and promoting the PGI(2) release of HUVEC at the concentration of 0.208 and 0.013 micromol/mL, respectively (p < 0.05). These data indicated that the method of live cell extraction coupled with HPLC-MS technology is feasible, rapid and useful for screening and analyzing potential bioactive components from TCMs.

摘要

本文建立了一种利用人脐静脉内皮细胞(HUVEC)提取物及高效液相色谱- Q-TOF/MS联用技术筛选和分析少腹逐瘀汤生物活性导向提取物(SF-11)中潜在生物活性成分的有效方法。此外,还研究了其对肾上腺素体外诱导的HUVEC损伤的保护作用。结果表明,SF-11显著抑制HUVEC内皮素(ET)释放并逆转其NO分泌(p<0.05),并促进HUVEC前列环素(PGI₂)释放(p<0.05)。利用活细胞提取物及HPLC-Q-TOF/MS联用技术从SF-11中筛选并鉴定出两种有效成分芍药苷和知母皂苷元。芍药苷和知母皂苷元对HUVEC的ET释放及NO分泌逆转具有显著抑制作用(p<0.05),与SF-11作用相似,且分别在0.208和0.013 μmol/mL浓度下促进HUVEC的PGI₂释放(p<0.05)。这些数据表明,活细胞提取物结合HPLC-MS技术的方法对于从中药中筛选和分析潜在生物活性成分是可行、快速且有用的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验